Witnessing An Insider Decision, Mitchell Kitayama Exercises Options Valued At $388K At Astrana Health

Mitchell Kitayama, Director at Astrana Health ASTH, reported a large exercise of company stock options on September 11, according to a new SEC filing.

What Happened: Kitayama, Director at Astrana Health, exercised stock options for 11,000 shares of ASTH stock. This information was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday. The exercise price of the options was $15.35 per share.

The latest update on Thursday morning shows Astrana Health shares up by 3.26%, trading at $50.68. At this price, Kitayama's 11,000 shares are worth $388,630.

All You Need to Know About Astrana Health

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.

Astrana Health: Financial Performance Dissected

Revenue Growth: Astrana Health's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 39.65%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.

Analyzing Profitability Metrics:

• Gross Margin: The company shows a low gross margin of 15.11%, suggesting potential challenges in cost control and profitability compared to its peers.

• Earnings per Share (EPS): Astrana Health's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.4.

Debt Management: Astrana Health's debt-to-equity ratio is below the industry average. With a ratio of 0.7, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

Valuation Analysis:

• Price to Earnings (P/E) Ratio: The P/E ratio of 34.09 is lower than the industry average, implying a discounted valuation for Astrana Health's stock.

• Price to Sales (P/S) Ratio: The Price to Sales ratio is 1.46, which is lower than the industry average. This suggests a possible undervaluation based on sales performance.

• EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): With an EV/EBITDA ratio lower than industry averages at 16.82, Astrana Health could be considered undervalued.

Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.

Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.

Unmasking the Significance of Insider Transactions

It's important to note that insider transactions alone should not dictate investment decisions, but they can provide valuable insights.

When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.

A new purchase by a company insider is a indication that they anticipate the stock will rise.

On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.

Exploring Key Transaction Codes

When it comes to transactions, investors tend to focus on those in the open market, detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S indicates a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.

Check Out The Full List Of Astrana Health's Insider Trades.

This article was generated by Benzinga's automated content engine and reviewed by an editor.